Proactive monitoring is always better than reactive treatment
The indications for these drugs continue to expand, as researchers are testing whether theyll treat other illnesses
Yes , when evaluated in controlled preclinical human systems, IGF-1 LR3 maintains receptor specificity and predictable pharmacokinetics
Surgical Complications: Though rare in 2026, risks include staple line leaks, internal hernias, or bowel obstructions
A novel HGF/SF Receptor (MET) agonist transiently delays the disease progression in an amyotrophic lateral sclerosis mouse model by promoting neuronal survival and dampening the immune Dysregulation
El nuevo medicamento se toma una vez al da, lo que permite adaptar la va de administracin a las necesidades y preferencias de los pacientes, aspecto que, obviamente, favorece la adherencia al tratamiento y con ello el control de la enfermedad 1